Skip to results
Modify your search
NARROW
1-20 of 101
Authors: Isabelle C van Gelder
Journal Article
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association
EP Europace, Volume 27, Issue 3, March 2025, euaf019, https://doi.org/10.1093/europace/euaf019
Published: 12 March 2025
Journal Article
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
EP Europace, Volume 26, Issue 12, December 2024, euae298, https://doi.org/10.1093/europace/euae298
Published: 24 December 2024
Journal Article
Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association
EP Europace, Volume 26, Issue 7, July 2024, euae178, https://doi.org/10.1093/europace/euae178
Published: 28 June 2024
Journal Article
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
EP Europace, Volume 26, Issue 4, April 2024, euae070, https://doi.org/10.1093/europace/euae070
Published: 09 April 2024
Journal Article
Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
EP Europace, Volume 25, Issue 5, May 2023, euad058, https://doi.org/10.1093/europace/euad058
Published: 27 March 2023
Journal Article
Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study
EP Europace, Volume 25, Issue 4, April 2023, Pages 1323–1331, https://doi.org/10.1093/europace/euac268
Published: 01 March 2023
Journal Article
Atrial fibrillation and heart failure temporality: does it matter?
EP Europace, Volume 25, Issue 2, February 2023, Pages 247–248, https://doi.org/10.1093/europace/euac255
Published: 28 December 2022
Journal Article
OFFICIAL STATEMENT
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper
EP Europace, Volume 25, Issue 1, January 2023, Pages 185–198, https://doi.org/10.1093/europace/euac144
Published: 18 October 2022
Journal Article
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
EP Europace, Volume 25, Issue 1, January 2023, Pages 6–27, https://doi.org/10.1093/europace/euac062
Published: 27 July 2022
Journal Article
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke
EP Europace, Volume 24, Issue 7, July 2022, Pages 1058–1064, https://doi.org/10.1093/europace/euab324
Published: 21 January 2022
Journal Article
New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?—Authors’ reply
EP Europace, Volume 24, Issue 6, June 2022, Pages 1037–1038, https://doi.org/10.1093/europace/euab317
Published: 24 December 2021
Journal Article
Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
EP Europace, Volume 24, Issue 4, April 2022, Page 564, https://doi.org/10.1093/europace/euab277
Published: 13 December 2021
Journal Article
Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial
EP Europace, Volume 24, Issue 6, June 2022, Pages 910–920, https://doi.org/10.1093/europace/euab270
Published: 13 November 2021
Journal Article
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
EP Europace, Volume 24, Issue 4, April 2022, Pages 552–564, https://doi.org/10.1093/europace/euab200
Published: 02 September 2021
Journal Article
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)
EP Europace, Volume 24, Issue 1, January 2022, Pages 71–164, https://doi.org/10.1093/europace/euab232
Published: 29 August 2021
Journal Article
Rate control drugs differ in the prevention of progression of atrial fibrillation
EP Europace, Volume 24, Issue 3, March 2022, Pages 384–389, https://doi.org/10.1093/europace/euab191
Published: 20 August 2021
Journal Article
Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
EP Europace, Volume 24, Issue 2, February 2022, Pages 193–201, https://doi.org/10.1093/europace/euab179
Published: 30 July 2021
Journal Article
Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery
EP Europace, Volume 23, Issue 12, December 2021, Pages 1922–1930, https://doi.org/10.1093/europace/euab136
Published: 01 July 2021
Journal Article
First-line treatment of persistent and long-standing persistent atrial fibrillation with single-stage hybrid ablation: a 2-year follow-up study
EP Europace, Volume 23, Issue 10, October 2021, Pages 1568–1576, https://doi.org/10.1093/europace/euab093
Published: 18 June 2021
Journal Article
Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study
EP Europace, Volume 23, Issue 9, September 2021, Pages 1359–1368, https://doi.org/10.1093/europace/euab062
Published: 26 April 2021
